Igene Biotechnology, Inc.
Igene Biotechnology, Inc. (IGNE) Stock Overview
Explore Igene Biotechnology, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
15.7K
P/E Ratio
-0.11
EPS (TTM)
N/A
ROE
0.05%
IGNE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Igene Biotechnology, Inc. (IGNE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.11 and a market capitalization of 15.7K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.